ducovest

AFL:NYE-AFLAC Incorporated (USD)

EQUITY | Insurance - Life | New York Stock Exchange

Last Closing

USD 109.8

Change

-0.98 (-0.88)%

Market Cap

USD 29.18B

Volume

1.88M

Analyst Target

USD 41.11
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Aflac Inc is a general business holding company and acts as a management company. The Company sells supplemental health and life insurance in the United States and Japan.

Company Website : http://www.aflac.com

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-28 )

Largest Industry Peers for Insurance - Life

Symbol Name Price(Change) Market Cap
MET-PA MetLife Inc Preferred Stock Se..

N/A

 USD 47.88B
MET-PE MetLife Inc Preferred Stock Se..

N/A

 USD 42.42B
PRU Prudential Financial Inc

N/A

 USD 38.41B
PUK Prudential PLC ADR

N/A

 USD 26.98B
PRI Primerica Inc

N/A

 USD 9.49B
JXN Jackson Financial Inc

N/A

 USD 6.14B
FG F&G Annuities & Life Inc.

N/A

 USD 5.18B
ANG-PB American National Group Inc

N/A

 N/A
MET-PF MetLife Inc Preferred Stock Se..

N/A

 N/A
GNW Genworth Financial Inc

N/A

 N/A

ETFs Containing AFL

MVFD Northern Lights Fund Trus.. 2.66 % 0.00 %

N/A

 USD 0.07B
LYLD LYLD 2.38 % 0.00 %

N/A

 USD 0.01B
CESG:LSE FIRST TRUST GLOBAL FUNDS .. 2.07 % 0.00 %

N/A

 N/A
CORP PIMCO Investment Grade Co.. 0.00 % 0.20 %

N/A

 USD 1.31B
EUSA iShares MSCI USA Equal We.. 0.00 % 0.15 %

N/A

 USD 1.21B
FHF:CA 0.00 % 0.77 %

N/A

 N/A
FLI:CA CI U.S. & Canada Lifeco C.. 0.00 % 0.92 %

N/A

 CAD 0.09B
FUM:CA 0.00 % 0.80 %

N/A

 N/A
IAK iShares U.S. Insurance ET.. 0.00 % 0.43 %

N/A

 N/A
IWR iShares Russell Mid-Cap E.. 0.00 % 0.19 %

N/A

 USD 36.41B
IWS iShares Russell Mid-Cap V.. 0.00 % 0.24 %

N/A

 USD 12.73B
JKI 0.00 % 0.30 %

N/A

 N/A
PHE.B:CA 0.00 % 0.97 %

N/A

 N/A
QSY 0.00 % 0.38 %

N/A

 N/A
CLRG 0.00 % 0.25 %

N/A

 N/A
DBX4:F Xtrackers - MSCI EM Europ.. 0.00 % 0.00 %

N/A

 N/A
VLIQ:XETRA 0.00 % 0.00 %

N/A

 N/A
VDLQ:LSE 0.00 % 0.00 %

N/A

 N/A
IMCV iShares Morningstar Mid-C.. 0.00 % 0.00 %

N/A

 USD 0.62B
FTGS:XETRA FIRST TRUST GLOBAL FUNDS .. 0.00 % 0.00 %

N/A

 N/A

Market Performance

  Market Performance vs. Industry/Classification (Insurance - Life) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.15% 68% D+ 83% B
Dividend Return 0.56% 18% F 31% F
Total Return 6.71% 68% D+ 83% B
Trailing 12 Months  
Capital Gain 27.88% 83% B 91% A-
Dividend Return 2.42% 50% F 44% F
Total Return 30.31% 83% B 91% A-
Trailing 5 Years  
Capital Gain 210.17% 73% C 87% B+
Dividend Return 22.66% 42% F 56% F
Total Return 232.82% 80% B- 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 23.02% 79% B- 84% B
Dividend Return 25.68% 79% B- 84% B
Total Return 2.66% 29% F 58% F
Risk Return Profile  
Volatility (Standard Deviation) 22.83% 68% D+ 46% F
Risk Adjusted Return 112.50% 89% A- 97% N/A
Market Capitalization 29.18B 100% F 96% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Insurance - Life) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 11.40 44% 70%
Price/Book Ratio 2.26 33% 37%
Price / Cash Flow Ratio 21.89 25% 15%
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity 22.64% 90% 87%
Return on Invested Capital 17.36% 89% 83%
Return on Assets 3.38% 90% 61%
Debt to Equity Ratio 28.36% 90% 74%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector